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A small-molecule fluorescent probe specific for
human pluripotent stem cells would serve as a
useful tool for basic cell biology research and stem
cell therapy. Screening of fluorescent chemical
libraries with human induced pluripotent stem cells
(iPSCs) and subsequent evaluation of hit molecules
identified a fluorescent compound (Kyoto probe 1
[KP-1]) that selectively labels human pluripotent
stem cells. Our analyses indicated that the selec-
tivity results primarily from a distinct expression
pattern of ABC transporters in human pluripotent
stem cells and from the transporter selectivity of
KP-1. Expression of ABCB1 (MDR1) and ABCG2
(BCRP), both of which cause the efflux of KP-1, is
repressed in human pluripotent stem cells. Although
KP-1, like other pluripotent markers, is not abso-
lutely specific for pluripotent stem cells, the identi-
fied chemical probe may be used in conjunction
with other reagents.INTRODUCTION
Human embryonic stem cells (hESCs) (Thomson et al., 1998)
and induced pluripotent stem cells (iPSCs) (Takahashi et al.,
2007) have been serving as valuable tools for basic bio-
logical research and as promising resources for regeneration
therapy. Despite advances, substantial challenges remain for
the clinical application of stem cells. One safety concern has
been posed by the appearance of teratomas in animal models
transplanted with cell samples containing a small number ofCeundifferentiated stem cells. Methods of detecting and ablating
undifferentiated stem cells are required for safer stem cell
therapy.
Antibodies against stage-specific embryonic antigens 4 and
5 (SSEA-4 and SSEA-5) have been used extensively to detect
human pluripotent stem cells (Henderson et al., 2002; Tang
et al., 2011; Thomson et al., 1998). SSEA-4 is a glycolipid
that is expressed in early embryos and, for unknown reasons,
is presented selectively on the surface of hESCs and embry-
onic carcinoma (EC) cells (Henderson et al., 2002). SSEA-5,
which is classified as an H-type 1 glycan, is a recently identi-
fied antigen specifically expressed in human pluripotent stem
cells (Tang et al., 2011). Other markers of human stem cells
include Oct3/Oct4 and Nanog, which are transcription factors
required for the maintenance of undifferentiated states of
stem cells and are downregulated upon differentiation (Cham-
bers et al., 2003; Mitsui et al., 2003; Niwa et al., 2000; Pesce
and Scho¨ler, 2001; Rosner et al., 1990). Although their anti-
bodies are highly useful for detecting pluripotent cells, these
unstable protein tools suffer from high cost and often require
fixation and permeabilization of cells. Alkaline phosphatase is
another routinely used marker of human stem cells (Shamblott
et al., 1998; Thomson et al., 1995). Although the assay for its
enzymatic activity provides a simple method for detecting
stem cells, this housekeeping enzyme is expressed in a number
of other cell types, and its specificity to pluripotent stem cells is
a major concern. A small molecule fluorescent probe specific
for human pluripotent stem cells would permit their rapid
detection and separation. Furthermore, small molecule probes
provide reversible detection that can be tuned by varying the
dose. Stable, chemically defined, and cost-effective synthetic
probes would offer significant advantages as tools for basic
research and for lowering the risk of tumor formation in stem
cell therapy.ll Reports 6, 1165–1174, March 27, 2014 ª2014 The Authors 1165
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Figure 1. Discovery of KP-1
(A) Chemical structure of KP-1.
(B) Bright-field image of hiPSCs on mouse STO feeder cells. Scale bar represents 300 mm.
(C) Fluorescence image of hiPSCs on feeder cells incubated with KP-1 (2 mM) for 3 hr. Scale bar represents 300 mm.
(D) Flow cytometric analysis of amixture of hiPSCs and feeder cells doubly stained with KP-1 and a-SSEA-4-Alexa 647. hiPSCs and feeder cells were dissociated
with Accutase into single cells and stained with KP-1 (2 mM) for 3 hr and a fluorescence-labeled anti-SSEA-4 (a-SSEA-4-Alexa 647) for 30 min.
(E–J) Effects of cell differentiation on the staining pattern of KP-1. (E) Bright-field and (H) fluorescent images are shown of a partially differentiated hiPSC colony
incubated with KP-1 (4 mM) for 4.5 hr. (F) Bright-field and (I) fluorescence images are shown of hESC colonies incubated with KP-1 (1 mM) for 2 hr. (G) Bright-field
and (J) fluorescence images are shown of partially differentiated hESC colonies incubated with KP-1 (1 mM) for 2 hr. hESCswere treated with 500 nM retinoic acid
for 4 days. Scale bars represent 450 mm.
See also Figures S1–S3.RESULTS
Discovery of Kyoto Probe 1
To identify a fluorescent probe that is selective for human plurip-
otent stem cells, we screened 326 fluorescent compounds from
chemical libraries (Ahn et al., 2007; Kawazoe et al., 2011). The
image-based screening using human iPS cells (hiPSCs) isolated
21 molecules that stained hiPSCs more strongly than they
stained feeder cells (mouse STO cells). We focused our subse-
quent efforts on a highly fluorescent rhodamine molecule (mole-
cule 1, Kyoto probe 1 [KP-1]), which displayed the greatest
selectivity (Figures 1A–1C). The excitation and emission spectra
and fluorescent properties of KP-1 are shown in Figure S1A.
The selectivity of KP-1 for hiPSCs was confirmed by flow
cytometry (Figures 1D, S1B, and S1C). Mixtures of hiPSCs and
feeder cells were treated with KP-1 (Figure S1B), an Alexa Fluor
647-labeled anti-SSEA-4 (Figure S1C), or both (Figure 1D). When
the cells were stained simultaneously with KP-1 and the anti-
SSEA-4, KP-1 stained essentially all of the SSEA-4-positive1166 Cell Reports 6, 1165–1174, March 27, 2014 ª2014 The Authorscells, but not the SSEA-4-negative cells. Thus, KP-1 is capable
of differentiating between hiPSCs and feeder cells. To examine
the proportion of hiPSCs that is stained by KP-1, we carried
out similar experiments using feeder-free culture conditions (Fig-
ures S1D–S1G). The results indicated that KP-1 stained 99.18%
of hiPSCs, whereas an SSEA-4 antibody labeled 98.17% of
hiPSCs.
An observation made during our evaluation of KP-1 further
confirmed its specificity for pluripotent stem cells. When iPSCs
are overgrown, central parts of the colonies tend to initiate
differentiation, due to contact inhibition (Bortell et al., 1992;
Green and Meuth, 1974). Treatment with KP-1 selectively
stained the undifferentiated parts of such colonies, but not
the central parts (Figures 1E and 1H). When similar experiments
were conducted with colonies of hESCs (Suemori et al., 2006),
the colonies were stained more strongly than the feeder cells
(Figures 1F and 1I). When the colonies were partially differenti-
ated by treatment with retinoic acid (Ben-Shushan et al., 1995),
the differentiated parts of the colonies were less densely
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Figure 2. Selective Staining of hESCs
by KP-1
(A and B) Fluorescence microscopic imaging of (A)
hESCs and (B) ESC-derived differentiated cells in
the presence of KP-1 (1 mM). Differentiated cells
were derived from hESCs by treatment with retinoic
acid (500 nM) for 4 days and treated with KP-1
(1 mM) for 1 hr. The left panels show bright-field
images, and the right panels show fluorescence
images. Scale bars represent 100 mm.
(C) Fluorescence histograms from flow cytometric
analysis of hESCs and the ESC-derived differenti-
ated cells.
See also Figure S2.stained (Figures 1G and 1J). Flow cytometric analysis of hESCs
and retinoid-treated differentiated cells revealed that ESCs
were stained 100-fold more strongly by KP-1 than the differ-
entiated cells (Figure 2). These observations suggest that KP-1
is capable of distinguishing between pluripotent stem cells and
differentiated cells.
Mitochondrial Localization of KP-1
What is the basis for the selectivity of KP-1? KP-1 appears to be
cell permeable, and its subcellular localization overlaps with that
of MitoTracker Red (MitoRed) (Minamikawa et al., 1999), a mito-
chondria-selective fluorescent marker (Figure S2). MitoRed
labeled mitochondria both in hiPSCs and feeder cells; however,
KP-1 stained mitochondria only in iPSCs (Figures S2A–S2E),
indicating that KP-1 localizes in the mitochondria of human
pluripotent stem cells. The staining pattern of KP-1 remained
the same in the presence of CCCP, an uncoupling reagent that
disrupts the mitochondrial membrane potential (Heytler, 1963;
Kasianowicz et al., 1984), indicating that the staining properties
of KP-1 are independent of the membrane potential (Figures
S2F–S2I).
To isolate mitochondrial proteins that interact with KP-1, we
synthesized a chloroacetyl derivative of KP-1 (Figure S3A).
Although this highly reactive derivative is slightly less selectiveCell Reports 6, 1165–1174than KP-1, perhaps due to its rapid for-
mation of covalent bonds to cellular
proteins (Svensson et al., 2002), it still
localized in mitochondria of hiPSCs
(Figures S3B–S3I). We treated hiPSCs
with the chloroacetyl derivative of KP-1
and used 2D SDS-PAGE to isolate mito-
chondrial proteins labeled with KP-1
(Figure S3J). Mass-sequencing analysis
(Mann et al., 2001) of the fluorescently
labeled bands revealed peptide se-
quences of aldehyde dehydrogenase 2
(ALDH2), a mitochondrial enzyme that
has been reported to interact with a rhoda-
mine derivative (Kim et al., 2011). Although
binding to ALDH2 might account for
the mitochondrial localization of KP-1,
this abundant enzyme is expressed in
numerous cell types (Greenfield and Pie-truszko, 1977) and is not likely to be responsible for the selec-
tivity of KP-1 for pluripotent stem cells.
KP-1 Selectivity and ABC Transporters
Concurrent with our study of KP-1, an independent project was
investigating the expression levels of 44 ATP binding cassette
(ABC) transporters in hESCs and iPSCs. ABC proteins trans-
port hydrophobic small molecules and lipids across cell
membranes in an ATP-dependent manner (Moitra and Dean,
2011; Ueda, 2011; Young and Holland, 1999) and are involved
in protection against xenobiotics and cholesterol homeostasis
(Ueda, 2011). The investigation with five lines of hESCs and
three lines of hiPSCs showed intriguing expression patterns
of four ABC proteins involved in xenobiotic efflux (Figure 3A).
RT-PCR experiments revealed that both hESCs and iPSCs
express ABCC1 (multidrug-resistance protein 1 [MRP1]) and
ABCG2 (breast cancer-resistance protein [BCRP]) at detectable
levels but have little, if any, expression of ABCB1 (MDR1) and
ABCC2 (MRP2) transporters. Expression levels of ABCB1 and
ABCG2 were markedly higher (29- and 24-fold, respectively)
in differentiated cells prepared with retinoic acid, which
express the differentiation marker, CDX2 (Bernardo et al.,
2011; Niwa et al., 2005), than in human pluripotent stem cells
(Figure 3B)., March 27, 2014 ª2014 The Authors 1167
A B
%
G
A
PD
H
1
2
3
Fo
ld
In
cr
ea
se
10
20
30
0
40
ABCB1
(MDR1)
ABCC1
(MRP1)
ABCG2
(BCRP)
ABCC2
(MRP2)
ABCB1
(MDR1)
ABCC1
(MRP1)
ABCG2
(BCRP)
ABCC2
(MRP2)
Figure 3. Expression Patterns of ABC Transporters in Human
Pluripotent Stem Cells
(A) Comparison of mRNA expression levels of ABCB1 (MDR1), ABCC1
(MRP1), ABCC2 (MRP2), and ABCG2 (BCRP) transporters among hESCs (blue
bar) and hiPSCs (red bar). Five hESC lines (KhESC-1, KhESC-2, KhESC-3,
KhESC-4, and KhESC-5 in a left-to-right bar) and three hiPSC lines (201B7,
IMR90-1, and IMR90-4, in a left-to-right bar) were examined.
(B) Fold increases of mRNA of ABCB1 (MDR1), ABCC1 (MRP1), ABCC2
(MRP2), and ABCG2 (BCRP) transporters between hESCs (blue bar) and
differentiated cells (red bar). Each bar shows an averaged value of the five
hESC lines (KhESC-1, KhESC-2, KhESC-3, KhESC-4, and KhESC-5).
See also Figure S4.We hypothesized that the selective staining of pluripotent
stem cells by KP-1 is due to increased expression of ABCB1
and ABCG2 in differentiated cells, resulting in the selective
export of KP-1. To investigate the role of ABCB1 and ABCG2
in the selectivity of KP-1, we established cell lines that stably ex-
press ABCB1 or ABCG2 (KB/ABCB1 and KB/ABCG2, respec-
tively) from the KB3-1 line of human epidermoid carcinoma cells,
which have undetectable expression levels of those transporters
(Taguchi et al., 1997; Ueda et al., 1987). We treated the cells with
KP-1 for 2 hr, captured their images using a fluorescence micro-
scope (Figures 4A and 4B), and quantified the signals (Figures 4C
and 4D). Parental KB3-1 cells were strongly stained by KP-1,
whereas fluorescent signals were significantly lower or undetect-
able in KB/ABCB1 and KB/ABCG2 cells. KP-1 staining of KB/
ABCB1 or KB/ABCG2 cells was restored by treatment with
cyclosporine A or fumitremorgin C (Figures 4A–4D), which are
known inhibitors of ABCB1 (Tamai and Safa, 1990) or ABCG2
(Allen et al., 2002), respectively. Similar experiments were con-
ducted with ABCC1 (MRP1), a transporter whose expression is
unchanged upon cell differentiation (Chen et al., 2001; Nagata
et al., 2000). Overexpression of ABCC1 did not result in export
of KP-1, whereas calcein AM, a known substrate of ABCC1 (Ver-
santvoort et al., 1995), was eliminated (Figures S4A and S4B).
These results collectively suggest that KP-1 is a selective sub-
strate for both ABCB1 and ABCG2.
We next examined the effects of transporter inhibitors on the
selectivity of KP-1 for hESCs. When differentiated cells derived
from ESCs were treated with cyclosporine A or fumitremorgin C,
the differentiated cells were labeled by KP-1 approximately 103
more strongly than those untreated with the inhibitors (Figures
4E and 4F). These results indicate that the selectivity of KP-1
depends on its efflux via ABCB1 and ABCG2, whose expression
is repressed in human pluripotent cells and induced upon
differentiation.1168 Cell Reports 6, 1165–1174, March 27, 2014 ª2014 The AuthorsSelectivity Profiling of KP-1 with Human Somatic Cells
If induction levels of ABCB1 and ABCG2 expression depend on
the direction and degree of differentiation from pluripotent stem
cells, the usefulness of KP-1 might be limited. Previous studies
have reported that either ABCG2 or ABCB1 is induced in early
hematopoiesis (Tang et al., 2010; Uchida et al., 2004; Zhou
et al., 2001); therefore, we examined KP-1 staining of hemato-
poietic cells derived from hESCs (Takayama et al., 2008, 2010)
(Figure 5A). Fluorescence-activated cell sorting (FACS) analysis
showed that KP-1 distinguishes between SSEA-4-positive
hESCs and human early hematopoietic cells expressing CD45,
CD235, CD41a, or CD43, suggesting that KP-1 is useful for
monitoring early hematopoiesis.
We next examined the ability of KP-1 tomonitor other clinically
important differentiation processes: cardiomyogenesis and neu-
rogenesis. KP-1 was capable of distinguishing between hiPSCs
and hiPSC-derived cardiomyocytes (Figures S5A and S5B), as
confirmed by flow cytometric analysis (Figure 5B). We used
RT-PCR to examine the expression patterns of 44 human ABC
transporters in cardiomyocytes derived from hiPSCs (Fig-
ure S4C). Surprisingly, neither ABCG2 nor ABCB1 was induced
during cardiomyogenesis. Instead, three ABC transporters,
ABCA1, ABCC5, and ABCD3, were induced during differentia-
tion (Figure S4C). The ability of two cell surface membrane
ABC transporters, ABCA1 and ABCC5, to cause efflux of KP-1
was examined by overexpressing each transporter in HEK293
cells. However, no clear efflux of KP-1 was observed from
these cells (data not shown). It is possible that cardiomyocytes
have other ABC transporter-independent mechanisms for
excluding KP-1.
In contrast to human cardiomyocytes, hiPSC-derived neu-
ronal stem cells (Morizane et al., 2011) were as strongly stained
by KP-1 as hiPSCs (Figures S5C and S5D). The inability of KP-1
to distinguish between hiPSCs and human neuronal stem cells
prompted us to examine staining patterns of KP-1 in a range
of human primary cells (Figures 6A–6I). FACS analysis showed
that KP-1 stained human brain astrocytes as strongly as
hiPSCs, consistent with our observation that KP-1 labels human
neuronal stem cells. In contrast, KP-1 exhibited weaker staining
patterns in human lung cells, human adrenal microvascular
cells, human prostate epithelial cells, human hepatocytes, hu-
man bronchial epithelial cells, and human brain microvascular
cells. These results are consistent with expression profiles of
ABC transporters in human tissues (Langmann et al., 2003):
human tissues associated with secretion (adrenal gland),
metabolic activity (liver), barrier systems (lung, bronchia), and
reproductive organs (prostate) tend to display strong expression
of ABC transporters. Overall, the results suggest that KP-1 is
useful for monitoring a wide range of differentiation processes
from human pluripotent stem cells, with the exception of
neurogenesis.
We also tested staining patterns of KP-1 with several human
cancer cell lines (Figures 6J–6L). KP-1 exhibited weaker staining
in HepG2 cells (hepatocellular carcinoma) and human EC
(1156QE) cells than in hiPSCs, whereas HeLa cells, a cervical
cancer cell line that displays low ABC transporter expression
(Ahlin et al., 2009), were labeled by KP-1 as strongly as hiPSCs.
Thus, KP-1 might find its use in classifying cancer cells.
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Figure 4. KP-1 Selectivity and ABC Trans-
porters
(A) Fluorescence microscopic images of KB3-1
cells and KB/ABCB1 cells. The cells were treated
with 1 mM KP-1 for 2 hr (left panel) or with 1 mM
KP-1 for 2 hr in the presence of 5 mM cyclosporine
A (CsA; right panel). Scale bars represent 2 mm.
(B) Fluorescence microscopic images of KB3-1
cells and KB/ABCG2 cells. The cells were treated
with 1mMKP-1 for 2 hr (left panel) orwith 1mMKP-1
for 2 hr in the presence of 10 mM fumitremorgin C
(FTC; right panel). Scale bars represent 2 mm.
(C and D) Quantitative analysis of the fluorescence
intensities of KP-1 in KB3-1 (open bar in C and D),
KB/ABCB1 (solid bar in C), and KB/ABCG2 (solid
bar in D) cells. It is evident that treatment with CsA
or FTC restores the staining of KP-1.
(E and F) Fluorescence histograms from flow
cytometric analysis of hESCs and ESC-derived
differentiated cells in thepresence of (E) 10mMCsA
or (F) 10 mM FTC. hESCs (red line) or differentiated
cells (blue line) were incubated with 1 mM KP-1 for
1 hr orwith 1mMKP-1 and10mM inhibitor (pink line)
for 1 hr. CsA and FTC were used as ABCB1
and ABCG2 transporter inhibitors, respectively.
Shaded histograms and gray line represent hESCs
and differentiated cells without KP-1, respectively.
See also Figure S4.KP-1 Staining during Reprogramming
One potential application of KP-1 might be its use in early
detection of reprogrammed cells during reprogramming. To
examine this potential application, the cells brightly stained
by KP-1 at an early stage of reprogramming were isolated
and cultured to determine whether they did in fact corre-
spond to fully reprogrammed iPSCs at later stages. Four re-
programming factors (Sox2, Oct3/Oct4, Klf4, and L-Myc)
were virally transfected into human adrenal microvascular cells,
which have broad, strong expression of ABC transporters
(Langmann et al., 2003). On day 7, the cells were treated with
2 mM KP-1 for 2 hr, then incubated overnight in fresh medium
without KP-1. FACS analysis showed a significant increase in
bright fluorescent cells among the transfected population (Fig-
ures S6A–S6D). The fluorescence intensity of the cells was
greater than that of mock-transfected cells and as strong as
in hiPSCs.Cell Reports 6, 1165–1174We isolated the 10% of cells most
brightly stained by KP-1 and cultured
them for another 3 weeks. Surprisingly,
only a small portion (<0.1%) of the cells
resulted in colonies of iPSCs after replat-
ing, and the reprogramming rates of the
brightly stained cells were no higher
than those of cells that were less strongly
stained by KP-1.
During the course of the present study,
the Yamanaka group independently ob-
tained and published a similar result with
an antibody against TRA-1-60, one of
the most specific markers of humanpluripotent cells (Tanabe et al., 2013). By day 7, 20% of the
transduced cells were positive for TRA-1-60. However, only a
small portion (1%) of the reseeded TRA-1-60-positive cells re-
sulted in the colonies of iPSCs on day 28, andmany of those cells
turned back to be negative for TRA-1-60 during subsequent
culture. Detailed analysis showed that reprogramming of cells
treated with the four reprogramming factors is initiated much
more frequently thanwaspreviously anticipated and thatmatura-
tion, rather than initiation, is the limiting step of the reprogram-
ming process. Together with our results with KP-1, these obser-
vations suggest that pluripotentmarkers do not necessarily allow
early detection of pluripotent stem cells during reprogramming.
DISCUSSION
Results of the present study raise several questions for further
investigation. First, what is the role of repressed expression of, March 27, 2014 ª2014 The Authors 1169
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Figure 5. Selectivity Profiling of KP-1 with Hematopoietic Cells and
Cardiomyocytes
(A) Flow cytometric analysis of KP-1 staining of hESCs and hematopoietic
cells. hESCs and hematopoietic cells derived from hESCs were treated with
1 mM KP-1 for 2 hr. After the removal of KP-1, differentiated cells or undiffer-
entiated cells were incubated for an additional 24 hr. Expression of cell surface
molecules (CD45, CD235, CD41a, CD43, and SSEA-4) was analyzed by flow
cytometry.
(B) Fluorescence histograms from flow cytometric analysis of hiPSCs and
cardiomyocytes. hiPSCs and cardiomyocytes derived from hiPSCs (IMR90-1)
were treated with 1 mM KP-1 for 1 hr. After the removal of KP-1, differentiated
cells or undifferentiated cells were incubated for an additional 3 hr.
See also Figure S5.ABCB1 and ABCG2 in pluripotent cells? Mixed results have pre-
viously been reported about the expression of ABCG2 in ESCs:
Zeng et al. observed low expression levels of ABCG2 in human,
but not mouse, ESCs (Zeng et al., 2009), and others detected
high-level expression of ABCG2 in hESCs (Apa´ti et al., 2008).
Our results support the model in which expression of ABCB1
and ABCG2 is repressed in hESCs and iPSCs. The finding that
KP-1 stains neuronal lineages, as well as pluripotent stem cells,
might provide insight. Both neuronal cells and pluripotent stem
cells are usually protected by the blood-brain barrier or repro-
ductive organs and, therefore, might not require extensive
expression of ABC transporters. Reduced ABC transporter
expression might make pluripotent stem cells and neuronal cells1170 Cell Reports 6, 1165–1174, March 27, 2014 ª2014 The Authorsmore sensitive to endogenous bioactive small molecules,
permitting highly sensitive spatial and temporal responses to
environmental signals. It is also possible that ABCB1 and
ABCG2 inhibit undifferentiated states of hESCs. Studies to
address these issues are in progress.
Second, how specific is the absence of ABCB1 and ABCG2 as
a marker for human pluripotent cells? The expression pattern of
ABC transporters might be one of many properties of human
pluripotent stem cells and might not be conserved in other
organisms. Previous screening of a similar chemical library
with mouse ESCs identified a molecule that was not hit during
the current screening (Im et al., 2010), consistent with recent
findings of properties that differ between human and mouse
pluripotent stem cells (Schnerch et al., 2010). Substrate specific-
ities and expression patterns of ABC transporters might differ
between pluripotent stem cells of humans and other species.
Finally, what are other potential applications of KP-1, in addi-
tion to detection of persistent undifferentiated stem cells in cell
samples prior to transplantation? Unfortunately, our results
demonstrated that KP-1 is not suited for early detection of plurip-
otent cells during reprogramming. However, another potential
application might be monitoring of pluripotency during mainte-
nance of hESCs or iPSCs. Visualization of hESCs or iPSCs using
this stable synthetic molecule is reversible and amenable to fine-
tuning via concentration and incubation time. No cytotoxicity of
KP-1 was evident in hiPSCs under our standard staining condi-
tions (1 or 2 mM for 2–7 hr), although cytotoxicity was detected
after 48 hr of incubation at higher concentrations. The IC50 value
at 48 hr was estimated to be 5.6 mM (Figure S6E). Thus, pro-
longed incubation should be avoided when KP-1 is used at
high concentrations. The staining patterns of KP-1 are time
dependent, due to the involvement of ABC transporters, and
4 hr of incubation usually provided clear results.
The use of KP-1 might lead to the discovery of compounds
that increase the activity of ABC transporters, either by inducing
differentiation of stem cells into ABC-expressing progeny or by
increasing the activity of ABC transporters in pluripotent stem
cells. KP-1 might also serve as a screening tool or starting point
for the discovery and design of cytotoxic drugs that are selective
for human pluripotent stem cells. In theory, cytotoxic com-
pounds with ABC transporter selectivity similar to that of KP-1
should eliminate pluripotent stem cells from amixture of differen-
tiated cells and undifferentiated cells.
Despite the unanswered questions, the discovery of KP-1 and
elucidation of its mechanism of action constitute significant
steps toward the goals of understanding the unusual character-
istics of and developing a highly specific probe for human plurip-
otent stem cells. We plan to distribute this chemical probe to the
research community for further evaluation and for use in basic
studies and clinical applications.
EXPERIMENTAL PROCEDURES
Chemical Library Screening
The chemical libraries of fluorescent compounds are combinations of
fluorescent chemicals found or designed in multiple laboratories (Ahn
et al., 2007; Kawazoe et al., 2011). hiPSCs (clone #201B2) were plated on
SNL feeder cells in 24-well plates. Five days after plating, each fluorescent
compound was added at the final concentration of 4 mM. After overnight
Figure 6. Staining Patterns of KP-1 with Human Somatic Cells
(A–L) Fluorescence histograms from flow cytometric analysis of (A) human stem cells, (B) feeder cells, (C–I) human primary cells, and (J–L) cancer cells.
(A) hiPSCs, (B) mouse SNL cells, (C) human lung cells, (D) human adrenal microvascular endothelial cells, (E) human prostate epithelial cells, (F) human brain
microvascular endothelial cells, (G) human hepatocyte cells, (H) human bronchial epithelial cells, and (I) human brain astrocyte cells are shown. (J) HepG2 cells,
(K) human EC (1156QE) cells, and (L) HeLa cells are shown. The cells were treated with 2 mMKP-1 at 37C for 2 hr. After the removal of KP-1, cells were incubated
at 37C for an additional 5–7 hr. See also Figure S6.
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incubation, fluorescence microscopic images were captured using a Key-
ence Biorevo.
Characterization of KP-1
hiPSCs (clone #201B7) were plated at a density of 23 105 cells/well of a 6-well
plate with mouse STO feeder cells. hiPSCs were also prepared under feeder-
free conditions. Six days after plating, the cells were incubated with 2 mMKP-1
for 3 hr, and fluorescence microscopic images were then captured. The cells
were dissociated into single cells with Accutase (Invitrogen) and stained with
a-SSEA-4-Alexa 647 for 30 min at room temperature. After washing, flow cy-
tometric analysis was performed using a MoFlo Astrios (Beckman Coulter
Genomics).
Fluorescence Microscopic Imaging of hiPSC Colonies
hiPSCs (clone #201B7) were plated on SNL feeder cells in 24- or 96-well
plates. Five days after plating, donut-shaped colonies of iPSCs were obtained.
Differentiation of the central parts of the colonies was confirmed by immuno-
staining with an SSEA-1 antibody. The cells were incubated with 4 mMKP-1 for
4.5 hr at 37C. Fluorescence microscopic images were taken using a Carl
Zeiss Axioskop.
Fluorescence Microscopic Imaging and Flow Cytometric Analysis of
hESCs and ESC-Derived Differentiated Cells
The hESC line, KhESC-1, was maintained as previously described (Suemori
et al., 2006). To induce differentiation, hESCs were seeded onto a Matrigel-
coated plate and cultured for 4 days with 500 nM all trans-retinoic acid
(Sigma-Aldrich; R2625) in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% (v/v) fetal bovine serum (FBS). After staining of hESCs or
the differentiated cells with 1 mM KP-1 for 2 hr, the cells were rinsed with PBS
and examined using an Olympus IX71 fluorescence microscope with a DP72
camera. For flow cytometric analysis, the cells were washed twice with ice-
cold PBS and dissociated with 0.25% trypsin-EDTA into a single cell suspen-
sion. Staining by KP-1 was quantified using a FACSCalibur flow cytometer
(Becton Dickinson). For the experiments with transporter inhibitors, cyclo-
sporin A or fumitremorgin C was added at the concentration of 10 mM, during
staining with KP-1.
Expression Profile of ABC Transporters
mRNA was extracted from five hESC lines (KhESC-1, KhESC-2, KhESC-3,
KhESC-4, and KhESC-5) and three hiPSC lines (IMR90-1, IMR90-4, and
201B7). First-strand cDNAs were synthesized with reverse transcriptase
(Applied Biosystems). Gene expression profiles were obtained by quantitative
real-time RT-PCR, using TaqMan Array Gene Signature 96-well plates with 44
human ABC transporters (Applied Biosystems) and four housekeeping genes
(GAPDH, 18S, HPRT1, and GUSB). Expression levels were normalized to
GAPDH.
Experiments with KB3-1 Model Cells
The expression vector of myc-tagged ABCG2 in pCDH-EF1-MCS-IRES-Puro
(System Biosciences) was introduced into 293T cells with psPAX2 and
pMD2.G vector (Addgene). The lentivirus produced was used to infect
KB3-1 cells, and a stable transformant, KB-ABCG2, was obtained by culturing
the infected cells in medium containing puromycin (1 mg/ml). KB3-1, KB/
ABCB1 (Taguchi et al., 1997), KB/ABCG2, and KB/ABCC1 (Nagata et al.,
2000) cells were maintained in DMEM supplemented with 10% FBS at 37C
in a humidified incubator (5% CO2). The cells were subcultured for 24–48 hr
in 35 mm glass base dishes (IWAKI), at a density of 4 3 105 cells per dish, in
DMEMcontaining 10% (v/v) FBS. The cells were then incubated in DMEMcon-
taining 10% (v/v) FBS and KP-1 (1 mM) or calcein AM (2 mM) with or without an
inhibitor (cyclosporine A: 5 mM, Wako Pure Chemicals Industries; fumitremor-
gin C: 10 mM, BioAustralis). After 2 hr incubation at 37C, the treated cells were
rinsed with PBS and observed in DMEM containing 10% (v/v) FBS using a
confocal microscope (LSM 700; Carl Zeiss). For quantitative analysis, KB3-1
model cells were subcultured in poly-L-lysine-coated 96-well optical bottom
plates (Nunc) for 24 hr, at a density of 23 104 cells per well, in DMEM contain-
ing 10% (v/v) FBS. The cells were then incubated for 1 hr in DMEM containing
10% (v/v) FBS and KP-1 (1 mM) with or without fumitremorgin C (10 mM). The1172 Cell Reports 6, 1165–1174, March 27, 2014 ª2014 The Authorstreated cells were rinsed with the medium and further incubated without
KP-1 for 1 hr at 37C. After washing with PBS, fluorescence intensity was
measured in PBS using a microplate reader (Infinite F200; Tecan). The cells
were also lysed with PBS containing 1% (w/v) Triton X-100, and protein
amounts were measured with BCA Protein Assay Reagent (Thermo Scientific).
Fluorescence intensity was normalized to the protein amounts. Experiments
were carried out in octuplicate.
Selectivity Profiling of KP-1 with Hematopoietic Cells
hESC clone Kyoto hESC (KhESC)-3 was obtained from the Institute for Frontier
Medical Sciences, Kyoto University (Kyoto), after approval for hESC use was
granted by the Minister of Education, Culture, Sports, Science, and Technol-
ogy of Japan (MEXT), and the review boards for ethics at the University of
Tokyo. KhESC-3 was cultured on irradiated mouse embryonic fibroblasts in
a 1:1 mixture of DMEM and Ham F-12 medium, supplemented with 0.1 mM
nonessential amino acids (Invitrogen), 2 mM L-glutamine (Invitrogen), 20%
(v/v) knockout serum replacement (Invitrogen), 0.1 mM 2-mercaptoethanol,
and 5 ng/ml basic fibroblast growth factor (bFGF; Upstate). The cells were
passaged every 3 days to maintain them in an undifferentiated state. The
mouse C3H10T1/2 cell line was purchased from the RIKEN BioResource Cen-
ter and cultured in Basal Medium Eagle (Invitrogen), containing 10% (v/v) FBS
and 2 mM L-glutamine. ESC differentiation medium was Iscove-modified
DMEM, supplemented with a cocktail of 10 mg/ml human insulin, 5.5 mg/ml
human transferrin, 5 ng/ml sodium selenite, 2 mM L-glutamine, 0.45 mM
a-monothioglycerol, 50 mg/ml ascorbic acid, and 15% (v/v) highly filtered
FBS (Cellect Gold; ICN Biomedicals), in the absence or presence of the cyto-
kines. Human vascular endothelial growth factor (VEGF) was purchased from
R&D Systems. The following antibodies were used: phycoerythrin (PE) anti-
human CD43 (eBioscience), Pacific Blue anti-human CD45, allophycocyanin
(APC) anti-human CD41a, Pacific Blue anti-human CD235 (Glycophorin A)
(BioLegend), and PE anti-human SSEA-4.
In order to differentiate hESCs into hematopoietic cells, small clumps of
hESCs (<100 cells treated with PBS containing 0.25% trypsin [Invitrogen],
1 mM CaCl2 [Sigma-Aldrich], and 20% (v/v) knockout serum replacement
[Invitrogen]) were transferred onto mitomycin-treated or irradiated C3H10T1/2
cells, and cocultured in hematopoietic cell differentiation medium with VEGF
(20 ng/ml), which was replaced every 3 days. On day12 after starting differenti-
ation, KP-1 was added to the culture medium (final concentration, 1 mM). The
cells were incubated for 2 hr, then washed twice with PBS, and changed to
ESC differentiation medium. Undifferentiated KhESC-3 was used as positive
control, and all cells were treated with KP-1. Differentiated cells or undifferenti-
ated cells were collected after 0, 6, and 24 hr, using treatment with 0.25%
trypsin-EDTA (Invitrogen). Expression of cell surface molecules and KP-1 fluo-
rescence were analyzed by flow cytometry (FACSAria II; Becton Dickinson).
KP-1 Staining of Cardiomyocytes
Cardiac differentiation was carried out as previously described with modifica-
tions (Minami et al., 2012; Wang et al., 2011). In brief, hiPSCs were cultured on
3.5 cm culture dishes coated with human laminin 211 (BioLamina). To enhance
generation of cardiac colonies, WNT signaling inhibitors were added for days
3–9 of cardiac differentiation. Cardiac colonies were harvested on day 15 and
cultured for 7–10 days in floating culture. A majority of the prepared cells ex-
pressed the cardiac markers: cardiac troponin T, a-actinin, and NKX2.5.
hiPSCs or iPSC-derived cardiomyocytes were treated with 1 mM KP-1 for
2 hr. The treated cells were rinsed with the medium and further incubated
without KP-1 for 3 hr at 37C. Fluorescent images were captured using an
Olympus IX71 with a DP72 camera. For flow cytometric analysis, hiPSCs
and iPSC-derived cardiomyocytes were dissociated into single cells by treat-
ment with trypsin for 10 min. Flow cytometric analysis was performed with a
FACSCalibur flow cytometer.
Flow Cytometric Analysis of Human Stem Cells, Feeder Cells,
Human Primary Cells, and Cancer Cells
Human lung cells, human prostate epithelial cells, human brain microvascular
endothelial cells, human hepatocyte cells, human bronchial epithelial cells, hu-
man brain astrocyte cells, and human EC (1156QE) cells were purchased from
DS Pharma Biomedical. Human adrenal microvascular endothelial cells were
purchased from Primary Cell. Human lung cells were cultured in RPMI 1640
medium (Gibco) supplemented with 2 mM L-glutamine (Gibco) and 25 mM
HEPES (Gibco). Human prostate epithelial cells, human brain microvascular
endothelial cells, human hepatocyte cells, and human brain astrocyte cells
were cultured on plates treated with attachment factor (Cell Systems) in
CSC complete recombinant medium (Cell Systems) supplemented with
2% (v/v) human recombinant growth factor (Cell Systems). Human bronchial
epithelial cells were cultured in BEBM medium (Lonza) supplemented with
0.4% (v/v) bovine pituitary extract (Lonza), 0.1% (v/v) human epithelial growth
factor (Lonza), 0.1% (v/v) hydrocortisone (Lonza), 0.1% (v/v) epinephrine
(Lonza), 0.1% (v/v) transferrin (Lonza), 0.1% (v/v) insulin (Lonza), 0.1% (v/v) ret-
inoic acid (Lonza), 0.1% (v/v) triiodothyronine (Lonza), and 0.1% (v/v) GA-1000
(gentamicin, amphotericin-B; Lonza). Human EC (1156QE) cells were cultured
in DMEM without sodium pyruvate (Nacalai) supplemented with 10% (v/v)
FBS. Human adrenal microvascular cells were cultured in mesenchymal
stem cell medium (ScienCell) supplemented with 5% (v/v) FBS (ScienCell),
1% (v/v) mesenchymal stem cell growth factor (ScienCell), and 1% (v/v)
penicillin/streptomycin (ScienCell). The cells were subcultured in 6-well plates
(Falcon) at a density of 13 105 to 53 105 cells per well. The cells were treated
with 2 mMKP-1 at 37C for 2 hr. After the removal of KP-1, cells were incubated
in fresh medium at 37C for an additional 5–7 hr. For flow cytometric analysis,
the cells were washed with PBS and dissociatedwith 0.25% trypsin-EDTA into
a single cell suspension. Staining by KP-1 was quantified using a FACSAria II
flow cytometer.
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